An early stage efficacy clinical trial to further evaluate EOS789
Latest Information Update: 14 Jul 2021
At a glance
- Drugs EOS 789 (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Sponsors Shanghai Alebund Pharmaceuticals
- 14 Jul 2021 New trial record